Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/173991
Targeting Splicing in the Treatment of Human Disease
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
The tightly regulated process of precursor messenger RNA (pre-mRNA) alternative splicing (AS) is a key mechanism in the regulation of gene expression. Defects in this regulatory process affect cellular functions and are the cause of many human diseases. Recent advances in our understanding of splicing regulation have led to the development of new tools for manipulating splicing for therapeutic purposes. Several tools, including antisense oligonucleotides and trans-splicing, have been developed to target and alter splicing to correct misregulated gene expression or to modulate transcript isoform levels. At present, deregulated AS is recognized as an important area for therapeutic intervention. Here, we summarize the major hallmarks of the splicing process, the clinical implications that arise from alterations in this process, and the current tools that can be used to deliver, target, and correct deficiencies of this key pre-mRNA processing event. Keywords: alternative splicing, precursor messenger RNA, therapy, genetic disease
Matèries (anglès)
Citació
Citació
SUÑÉ POU, Marc, PRIETO-SÁNCHEZ, Silvia, BOYERO-CORRAL, Sofía, MORENO CASTRO, Cristina, EL YOUSFI, Younes, SUÑÉ I NEGRE, Josep m. (josep maria), HERNÁNDEZ-MUNAIN, Cristina, SUÑÉ, Carlos. Targeting Splicing in the Treatment of Human Disease. _Genes_. 2017. Vol. 8, núm. 87, pàgs. 1-17. [consulta: 24 de gener de 2026]. ISSN: 2073-4425. [Disponible a: https://hdl.handle.net/2445/173991]